Concepedia
Statistics
Publications
21
Citations
4.7K
H-Index
19
Active since
1998
Affiliations
John F. Kennedy Medical Center(Current)
Cleveland Clinic
University of California San Diego
Hackensack University Medical Center
University of Pennsylvania
Joseph Landolfi is an author at John F. Kennedy Medical Center specializing in oncology, medicine, and brain tumors.
Publications per year
1998–2022
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2015 · 1.2K citations · Full text
Medicine, Oncology, Radiation Oncology +15
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations
Medicine, Oncology, Pharmacology +13
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T. Wong, Andrew A. Kanner et al. · European Journal of Cancer · 2012 · 847 citations
Medicine, Neurosurgery, Oncology +14
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y. Wen, David A. Reardon, Terri S. Armstrong et al. · Clinical Cancer Research · 2019 · 272 citations · Full text
Medicine, Immunology, Oncology +17
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan et al. · Science Translational Medicine · 2016 · 199 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 21